AbbVie Overseas S.à.r.l.
USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2020–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Abbvie ranks #44,348 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.
- #44,348
- of 49,997 US assignees by volume
- 2nd percentile
- by Innovation Score (13.3/100)
- 1.6
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R44348 · Foreign Corporation #44,348 · 5 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 5 grants
- LOWER-Q #44,348/49,997
- PHOTO-FINISH Aalto-korkeakoulusää…
- CPC-NARROW A61P · 3 areas
- INNOV-LOW 13.3/100
- CLAIMS-SPARSE 1.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2020–2021 · 2y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Aalto-korkeakoulusäätiö (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Abbvie’s 13.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Abbvie
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- AbbVie Overseas S à… · this assignee 13
AbbVie Overseas S à… · this assignee
13 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Abbvie's Innovation Score is 13.3/100 (2nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Abbvie?
Each dot is one of Abbvie’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Abbvie’s own 1.6 claims/patent is at or below the 13.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Abbvie's grants concentrate
AbbVie Overseas S.à.r.l. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (3 grants) versus a trough of 2 in 2021. By volume, Abbvie sits between Azla Inc. and Absolutions Med, Inc..
Who files at AbbVie's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Azla
Azla Inc.
5 patents
- AZZ WSI
AZZ WSI LLC
5 patents
- Aalto-korkeakoulu…
Aalto-korkeakoulusäätiö
5 patents
- Aawaaz
Aawaaz inc.
5 patents
- Abgene
Abgene Limited
5 patents
- Ableton
Ableton AG
5 patents
- Absolute Completi…
Absolute Completion Technologies Ltd.
5 patents
- Absolutions Med
Absolutions Med, Inc.
5 patents
- Abbvie Overseas S… ◀
AbbVie Overseas S.à.r.l.
5 patents
What this shows AbbVie holds 5 patents at rank #44,713, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near AbbVie
By rank, the assignees closest to #44,713 in granted patent volume.
- Azla Inc. #44,709 · 5 patents
- AZZ WSI LLC #44,710 · 5 patents
- Aalto-korkeakoulusäätiö #44,711 · 5 patents
- Aawaaz inc. #44,712 · 5 patents
- Abgene Limited #44,714 · 5 patents
- Ableton AG #44,715 · 5 patents
- Absolute Completion Technologies Ltd. #44,716 · 5 patents
- Absolutions Med, Inc. #44,717 · 5 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in AbbVie's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Abbvie's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
13 2nd percentile higher than 2% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 3 | 60.0% |
| 2021 | 2 | 40.0% |
Which technologies does AbbVie Overseas S.à.r.l. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
AbbVie Overseas S.à.r.l.'s patent record in context - here's where to go next.
- AbbVie Overseas S.à.r.l.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #44,348 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare AbbVie Overseas S.à.r.l. against Azla Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 13.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.